RICHARD PFENNIGER - 20 Aug 2021 Form 4 Insider Report for Cocrystal Pharma, Inc. (COCP)

Role: Director
Signature: /s/ Richard Pfenniger
Issuer symbol: COCP
Transactions as of: 20 Aug 2021
Net transactions value: +$41,120
Form type: 4
Filing time: 23 Aug 2021, 18:02:05 UTC
Previous filing: 20 Jul 2021
Next filing: 04 Oct 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COCP	Common Stock	Purchase	$41,120	+40,000		$1.03	40,000	20 Aug 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions ranging from $1.02 to $1.03, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in the preceding sentence.

Content

The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions ranging from $1.02 to $1.03, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in the preceding sentence.